Oncology and Hematology - Global Oncology Academy

225-240 of 789

Perioperative Immunotherapy Strategies in Resectable NSCLC Care
Perioperative Immunotherapy Strategies in Resectable NSCLC Care
Project Oncology®
Perioperative Immunotherapy Strategies in Resectable NSCLC Care
Charles Turck, PharmD, BCPS, BCCCP; Martin Dietrich, MD, PhD
- Charles Turck, PharmD, BCPS, BCCCP
- Martin Dietrich, MD, PhD
Smoking Status Predicts Worse Survival in Non-Melanoma Skin Cancer
Smoking Status Predicts Worse Survival in Non-Melanoma Skin Cancer
Project Oncology®
Smoking Status Predicts Worse Survival in Non-Melanoma Skin Cancer
Teledermatology Enables Earlier Diagnosis of Cutaneous Squamous Cell Carcinoma
Teledermatology Enables Earlier Diagnosis of Cutaneous Squamous Cell Carcinoma
Project Oncology®
Teledermatology Enables Earlier Diagnosis of Cutaneous Squamous Cell Carcinoma
Alectinib vs Crizotinib in ALK+ NSCLC: Final ALEX Data
Alectinib vs Crizotinib in ALK+ NSCLC: Final ALEX Data
AudioAbstracts
Alectinib vs Crizotinib in ALK+ NSCLC: Final ALEX Data
Ryan Quigley
- Ryan Quigley
Shared Decision-Making in Squamous Cell Carcinoma of the Anal Canal
Shared Decision-Making in Squamous Cell Carcinoma of the Anal Canal
Project Oncology®
Shared Decision-Making in Squamous Cell Carcinoma of the Anal Canal
Brian P. McDonough, MD, FAAFP; Richard Kim, MD
- Brian P. McDonough, MD, FAAFP
- Richard Kim, MD
The Epigenetics of Lung Cancer Dormancy and Relapse
The Epigenetics of Lung Cancer Dormancy and Relapse
Project Oncology®
The Epigenetics of Lung Cancer Dormancy and Relapse
Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Project Oncology®
Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
CME/CE
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
Mariana C. Castells, MD, PhD; Tsewang Tashi, MD
0.25 credits
- Mariana C. Castells, MD, PhD
- Tsewang Tashi, MD
0.25 credits
The Past, Present, and Future of Metastatic Breast Cancer Care
The Past, Present, and Future of Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast Cancer
The Past, Present, and Future of Metastatic Breast Cancer Care
Ryan Quigley; Gregory Vidal, MD, PhD
- Ryan Quigley
- Gregory Vidal, MD, PhD
Advancing Care for Men with Breast Cancer
Advancing Care for Men with Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Advancing Care for Men with Breast Cancer
Jose Pablo Leone, MD
- Jose Pablo Leone, MD
Protecting Heart Health in Metastatic Breast Cancer
Protecting Heart Health in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Protecting Heart Health in Metastatic Breast Cancer
Ryan Quigley; Gregory Vidal, MD, PhD
- Ryan Quigley
- Gregory Vidal, MD, PhD
Evolving Approaches to Early-Onset CRC Detection
Evolving Approaches to Early-Onset CRC Detection
On the Frontlines of Colorectal Cancer
Evolving Approaches to Early-Onset CRC Detection
Peter Buch, MD, FACG, AGAF, FACP
- Peter Buch, MD, FACG, AGAF, FACP
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Project Oncology®
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Charles Turck, PharmD, BCPS, BCCCP; Marwan G. Fakih, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Marwan G. Fakih, MD
Comparing Photodynamic Therapy Approaches in Basal Cell Carcinoma
Comparing Photodynamic Therapy Approaches in Basal Cell Carcinoma
AudioAbstracts
Comparing Photodynamic Therapy Approaches in Basal Cell Carcinoma
Ryan Quigley
- Ryan Quigley
Closing Gaps in CRC Screening: Patient-Centered Strategies
Closing Gaps in CRC Screening: Patient-Centered Strategies
On the Frontlines of Colorectal Cancer
Closing Gaps in CRC Screening: Patient-Centered Strategies
Peter Buch, MD, FACG, AGAF, FACP
- Peter Buch, MD, FACG, AGAF, FACP
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Project Oncology®
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC

15/11